Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $2.49 billion. The enterprise value is $3.65 billion.
Important Dates
The next estimated earnings date is Monday, May 4, 2026, after market close.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 35.22 million shares outstanding. The number of shares has decreased by -0.28% in one year.
| Current Share Class | 35.22M |
| Shares Outstanding | 35.22M |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | -3.40% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 106.67% |
| Float | 34.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 14.36 |
| PS Ratio | 2.13 |
| Forward PS | 1.96 |
| PB Ratio | 84.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.09 |
| P/OCF Ratio | 7.51 |
| PEG Ratio | 0.90 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.19, with an EV/FCF ratio of 13.35.
| EV / Earnings | n/a |
| EV / Sales | 3.13 |
| EV / EBITDA | 10.19 |
| EV / EBIT | 13.94 |
| EV / FCF | 13.35 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 41.84.
| Current Ratio | 1.33 |
| Quick Ratio | 0.69 |
| Debt / Equity | 41.84 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 4.54 |
| Interest Coverage | 3.34 |
Financial Efficiency
Return on equity (ROE) is -133.66% and return on invested capital (ROIC) is 20.61%.
| Return on Equity (ROE) | -133.66% |
| Return on Assets (ROA) | 8.91% |
| Return on Invested Capital (ROIC) | 20.61% |
| Return on Capital Employed (ROCE) | 19.99% |
| Weighted Average Cost of Capital (WACC) | 9.29% |
| Revenue Per Employee | $778,400 |
| Profits Per Employee | -$111,400 |
| Employee Count | 1,500 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 3.70 |
Taxes
In the past 12 months, Ingevity has paid $8.20 million in taxes.
| Income Tax | 8.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.90% in the last 52 weeks. The beta is 1.31, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +62.90% |
| 50-Day Moving Average | 69.19 |
| 200-Day Moving Average | 56.93 |
| Relative Strength Index (RSI) | 56.50 |
| Average Volume (20 Days) | 400,977 |
Short Selling Information
The latest short interest is 1.28 million, so 3.65% of the outstanding shares have been sold short.
| Short Interest | 1.28M |
| Short Previous Month | 1.31M |
| Short % of Shares Out | 3.65% |
| Short % of Float | 3.67% |
| Short Ratio (days to cover) | 3.22 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.17 billion and -$167.10 million in losses. Loss per share was -$4.61.
| Revenue | 1.17B |
| Gross Profit | 461.50M |
| Operating Income | 261.80M |
| Pretax Income | -142.10M |
| Net Income | -167.10M |
| EBITDA | 358.10M |
| EBIT | 261.80M |
| Loss Per Share | -$4.61 |
Full Income StatementBalance Sheet
The company has $78.10 million in cash and $1.24 billion in debt, with a net cash position of -$1.16 billion or -$33.06 per share.
| Cash & Cash Equivalents | 78.10M |
| Total Debt | 1.24B |
| Net Cash | -1.16B |
| Net Cash Per Share | -$33.06 |
| Equity (Book Value) | 29.70M |
| Book Value Per Share | 0.84 |
| Working Capital | 112.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $331.20 million and capital expenditures -$57.70 million, giving a free cash flow of $273.50 million.
| Operating Cash Flow | 331.20M |
| Capital Expenditures | -57.70M |
| Depreciation & Amortization | 96.30M |
| Net Borrowing | -193.60M |
| Free Cash Flow | 273.50M |
| FCF Per Share | $7.76 |
Full Cash Flow StatementMargins
Gross margin is 39.53%, with operating and profit margins of 22.42% and -14.31%.
| Gross Margin | 39.53% |
| Operating Margin | 22.42% |
| Pretax Margin | -12.17% |
| Profit Margin | -14.31% |
| EBITDA Margin | 30.67% |
| EBIT Margin | 22.42% |
| FCF Margin | 23.42% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.28% |
| Shareholder Yield | 0.28% |
| Earnings Yield | -6.72% |
| FCF Yield | 11.00% |
Analyst Forecast
The average price target for Ingevity is $72.50, which is 2.74% higher than the current price. The consensus rating is "Buy".
| Price Target | $72.50 |
| Price Target Difference | 2.74% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 2.29 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.29 |
| Piotroski F-Score | 6 |
